Ningfei Ji

1.3k citations
62 papers · 925 · 1 hit paper · h-index 16

Impact in

  • Genetics top 5%
    • Mesenchymal stem cell research
  • Neurology top 10%
    • Long-Term Effects of COVID-19

Papers in

Ningfei Ji

57 papers receiving 911 citations

Ningfei Ji's Hit Papers

Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells 2020 · 214 citations
2140+2+4Years since publication50100150200

Peers

Ningfei Ji
Comparison fields: 5 of 98
  • Genetics 151
  • Neurology 108
  • Infectious Diseases 137
  • Immunology 140
  • Physiology 119
Replace Hong Peng with:
Hong Peng China
Carl W. White United States
Shuang‐Qin Yi Japan
Katherine Ma O’Reilly Ireland
Thomas Nebe Germany
Takahiro Kuragano Japan
Pingli Wang China
Τheodoros Karampitsakos Greece
Soumyaroop Bhattacharya United States
M. Spycher Switzerland
Ningfei Ji relative to Hong Peng China Hong Peng's profile →
Citations per field
00.5×5.6×
Hong Peng · 1×
Citations per year

Countries citing papers authored by Ningfei Ji

Since Specialization
Citations

This map shows the geographic impact of Ningfei Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ningfei Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ningfei Ji more than expected).

Fields of papers citing papers by Ningfei Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ningfei Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ningfei Ji. The network helps show where Ningfei Ji may publish in the future.

Co-authors

The 25 scholars most cited alongside Ningfei Ji, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ningfei Ji Line = papers co-authored together Ningfei Ji links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells
Hit paper breakdown →
2020214
2 201575
3 202071
4 201468
5 202258
6 201127
7 201826
8 202125
9 202022
10 202022
11 202320
12 202118
13 202318
14 202116
15 201916
16 202015
17 202115
18 201815
19 202213
20 201813

About Ningfei Ji

Ningfei Ji is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Immunology, Infectious Diseases and Molecular Biology, having authored 62 papers that have together received 925 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (12 papers), IL-33, ST2, and ILC Pathways (10 papers), COVID-19 Clinical Research Studies (8 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Neonatal Respiratory Health Research (4 papers), Fungal Infections and Studies (3 papers) and Pediatric health and respiratory diseases (3 papers). The work is most often cited by research in Genetics (151 citations), Neurology (108 citations), Infectious Diseases (137 citations), Immunology (140 citations) and Physiology (119 citations). Ningfei Ji has collaborated with scholars based in China. Frequent co-authors include Mao Huang, Mingshun Zhang, Zhongqi Chen, Zhengxia Wang, Ganzhu Feng, Mao Huang, Jing Wei, Mingjing Wu, Jiaxin Yan and Kaili Deng. Their work appears in journals such as International Immunopharmacology, Annals of Translational Medicine, Allergy Asthma and Immunology Research, Journal of Biomedical Nanotechnology and Stem Cell Research & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact